Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy

Diabetes Care - United States
doi 10.2337/dc11-1693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Effects of the SGLT2 Inhibitor Dapagliflozin on Cardiac Function Evaluated by Impedance Cardiography in Patients With Type 2 Diabetes. Secondary Analysis of a Randomized Placebo-Controlled Trial

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2018English

For Type 2 Diabetes Poorly Controlled by Metformin Monotherapy, the Addition of Any Non-Insulin Antidiabetic Drug Reduces HbA1c to a Similar Extent, but With Differing Effects on Weight and Hypoglycaemic Risk

Evidence-Based Medicine
Medicine
2011English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model

Physiological Reports
Physiology
2019English

Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients With Type 2 Diabetes

Hormone and Metabolic Research
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2019English

The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2017English

Economic Evaluation of Dapagliflozin Versus Metformin in Chinese Patients Whose Diabetes Is Inadequately Controlled With Diet and Exercise

Cost Effectiveness and Resource Allocation
Health Policy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy